Syndrome of Orthostatic Hypotension with Supine Hypertension: A Therapeutic Dilemma for Cardiologists
M. Naaim *
Autonomic Nervous Systems Exploration Unit, Cardiology Department, ARRAZI Hospital, Mohammed VI University Hospital, Marrakech, Morocco.
N. Malhabi
Autonomic Nervous Systems Exploration Unit, Cardiology Department, ARRAZI Hospital, Mohammed VI University Hospital, Marrakech, Morocco.
M. Ztati
Autonomic Nervous Systems Exploration Unit, Cardiology Department, ARRAZI Hospital, Mohammed VI University Hospital, Marrakech, Morocco.
M. Eljamili
Autonomic Nervous Systems Exploration Unit, Cardiology Department, ARRAZI Hospital, Mohammed VI University Hospital, Marrakech, Morocco.
S. El Karimi
Autonomic Nervous Systems Exploration Unit, Cardiology Department, ARRAZI Hospital, Mohammed VI University Hospital, Marrakech, Morocco.
M. El Hattaoui
Autonomic Nervous Systems Exploration Unit, Cardiology Department, ARRAZI Hospital, Mohammed VI University Hospital, Marrakech, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Orthostatic hypotension (OH) and supine hypertension (SH) are two cardiovascular symptoms of autonomic failure that frequently coexist in the same patient.
Clinicians are faced with a dilemma because aggressive orthostatic intolerance treatment can exacerbate supine hypertension, and vice versa for supine hypertension management.
The objective of our article is to provide a better framework for the clinical evaluation, the right choice of therapeutic options and the improvement of the quality of life of patients with OH-SH syndrome. For these reasons, we report three observations, whose etiologies, clinical presentation, and treatment are different, namely diabetes, multiple system atrophy type C (MSA) and Parkinson's disease.
Keywords: Orthostatic hypotension, supine hypertension, cardiovascular symptoms
How to Cite
References
Roxana Darabont1, Elena Alina Badulescu. The difficult scenario of supine hypertension; 13 Dec 2018.
Ahmed A, Grubb B, Zaman L, Kanjwal K. Syndrome of supine hypertension with orthostatic hypotension. A Nightmare for Physicians; 1 Mars 2016.
Fanciulli A, Jordan J, Biaggioni I, Calandra–Buonaura G, Cheshire WP, Cortelli P et al. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS). Clin Auton Res. 1 August 2018;28(4): 355‑62.
Parati G, Stergiou G, O’Brien E, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. July 2014;32(7):1359‑66.
Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. July 2013;31(7):1281‑357.
Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. Apr. 2011; 21(2):69‑72.
Gibbons CH, Schmidt P, Biaggioni I, Frazier-Mills C, Freeman R, Isaacson S, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 1 August 2017; 264(8):1567‑82.
Kanjwal K, George A, Figueredo VM, Grubb BP. Orthostatic hypotension: Definition, diagnosis and management. J Cardiovasc Med (Hagerstown). Feb. 2015; 16(2):75‑81.
Naschitz JE, Slobodin G, Elias N, Rosner I. The patient with supine hypertension and orthostatic hypotension: A clinical dilemma. Postgrad Med J. Apr. 2006;82(966): 246‑53.
Freeman R. Syncope. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, éditeurs. Harrison’s Principles of Internal Medicine [Internet]. 20e éd. New York, NY: McGraw-Hill Education. [cite 27 August 2022];2018 Disponiblesur:accessmedicine.mhmedical.com/content.aspx?aid=1160047030
Md MLC. Orthostatic hypotension and supine hypertension in the patient with autonomic failure. Can Journ Gen Int Med [Internet]. [cite 12 avr 2022]. 2014;9(3). Disponible sur: https://www.cjgim.ca
Goldstein DS, Sharabi Y. Neurogenic orthostatic hypotension: A patho-physiological approach. Circulation. 6 Jan. 2009;119(1):139‑46.
Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group - PubMed [Internet]. [cite 27 August 2022].
Available:https://pubmed.ncbi.nlm.nih.gov/1592445/
Berganzo K, Díez-Arrola B, Tijero B, Somme J, Lezcano E, Llorens V, et al. Nocturnal hypertension and dysautonomia in patients with Parkinson’s disease: Are they related? J Neurol. July 2013;260(7): 1752‑6.
Palma JA, Gomez-Esteban JC, Norcliffe-Kaufmann L, Martinez J, Tijero B, Berganzo K, et al. Orthostatic hypotension in Parkinson disease: How much you fall or how low you go? Mov Disord. 15 Apr. 2015; 30(5):639‑45.
Masaki KH, Schatz IJ, Burchfiel CM, Sharp DS, Chiu D, Foley D, et al. Orthostatic hypotension predicts mortality in elderly men: The Honolulu Heart Program. Circulation. 24 Nov 1998;98(21):2290‑5.
Angelousi A, Girerd N, Benetos A, Frimat L, Gautier S, Weryha G, et al. Association between orthostatic hypotension and cardiovascular risk, cerebrovascular risk, cognitive decline and falls as well as overall mortality: A Systematic Review and Meta-Analysis. J Hypertens. August 2014; 32(8):1562‑71; Discussion 1571.
Velilla-Zancada SM, Escobar-Cervantes C, Manzano-Espinosa L, Prieto-Diaz MA, Ramalle-Gomara E, Vara-Gonzalez LA. Impact of variations in blood pressure with orthostatism on mortality: The HOMO study. Blood Press Monit. August 2017; 22(4):184‑90.
Elzanaty AM, Saeyeldin A, Royfman R, Maraey A, Khalil M, Aboul-Nour H, et al. Short-term Outcomes of Hypertensive Crises in Patients with Orthostatic Hypotension. Curr Probl Cardiol. Feb. 2023;48(2):101455.
Vagaonescu TD, Saadia D, Tuhrim S, Phillips RA, Kaufmann H. Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet. 26 Feb. 2000;355(9205):725‑6.
Maule S, Milan A, Grosso T, Veglio F. Left ventricular hypertrophy in patients with autonomic failure. Am J Hypertens. oct 2006;19(10):1049‑54.
Garland EM, Gamboa A, Okamoto L, Raj SR, Black BK, Davis TL, et al. Renal impairment of pure autonomic failure. Hypertension. Nov 2009;54(5):1057‑61.
Wang F, Zhao H, Yang C, Kong G, Song L, Li C, et al. Association of blood pressure in the supine position with target organ damage in subjects over 60 years old. J Int Med Res. Feb. 2017;45(1):123‑33.
Fanciulli A, Göbel G, Ndayisaba JP, Granata R, Duerr S, Strano S, et al. Supine hypertension in Parkinson’s disease and multiple system atrophy. Clin Auton Res. Apr. 2016;26(2):97‑105.
Umehara T, Matsuno H, Toyoda C, Oka H. Clinical characteristics of supine hypertension in de novo Parkinson disease. Clin Auton Res. Feb. 2016;26(1): 15‑21.
Pavy-Le Traon A, Piedvache A, Perez-Lloret S, Calandra-Buonaura G, Cochen-De Cock V, Colosimo C, et al. New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study. J Neurol Neurosurg Psychiatry. May 2016;87(5): 554‑61.
Fanciulli A, Strano S, Ndayisaba JP, Goebel G, Gioffrè L, Rizzo M, et al. Detecting nocturnal hypertension in Parkinson’s disease and multiple system atrophy: proposal of a decision-support algorithm. J Neurol. July 2014;261(7): 1291‑9.
Plaschke M, Trenkwalder P, Dahlheim H, Lechner C, Trenkwalder C. Twenty-four-hour blood pressure profile and blood pressure responses to head-up tilt tests in Parkinson’s disease and multiple system atrophy. J Hypertens. Oct 1998;16(10): 1433‑41.
Bleasdale-Barr KM, Mathias CJ. Neck and other muscle pains in autonomic failure: their association with orthostatic hypotension. J R Soc Med. July 1998; 91(7):355‑9.
Gibbons CH, Freeman R. Orthostatic dyspnea: A neglected symptom of orthostatic hypotension. Clin Auton Res. Feb 2005;15(1):40‑4.
Robertson D, Kincaid DW, Haile V, Robertson RM. The head and neck discomfort of autonomic failure: An Unrecognized Aetiology of Headache. Clin Auton Res. June 1994;4(3):99‑103.
Guaraldi P, Poda R, Calandra-Buonaura G, Solieri L, Sambati L, Gallassi R, et al. Cognitive Function in Peripheral Autonomic Disorders. PLoS One. 2014; 9(1):e85020.
Centi J, Freeman R, Gibbons CH, Neargarder S, Canova AO, Cronin-Golomb A. Effects of orthostatic hypotension on cognition in Parkinson disease. Neurology. 3 Jan 2017;88(1):17‑24.
Davidson C, Smith D, Morgan DB. Diurnal pattern of water and electrolyte excretion and body weight in idiopathic orthostatic hypotension. The Effect of Three Treatments. Am J Med. Nov 1976;61(5): 709‑15.
Ikeda T, Matsubara T, Sato Y, Sakamoto N. Circadian blood pressure variation in diabetic patients with autonomic neuropathy. J Hypertens. May 1993;11(5): 581‑7.
Mann S, Bellamy GR, Hunyor SN, Raftery EB, Ingall T, Bannister R. Supine hypertension, blood pressure variability and circadian rhythm in autonomic failure: The role of ambulatory intra-arterial monitoring. Clin Exp Pharmacol Physiol. August 1984;11(4):347‑50.
Eslami M, Mollazadeh R, Mirshafiee S, Sehat P, Alizadeh F, Emkanjoo Z, et al. Postural orthostatic tachycardia syndrome and orthostatic hypotension post Covid-19. Infect Disord Drug Targets. 2023;23(1): e100622205846.
Ahmed A, Ruzieh M, Kanjwal S, Kanjwal K. Syndrome of supine hypertension with orthostatic hypotension: Pathophysiology and Clinical Approach. Current Cardiology Reviews. 1 Feb 2020;16(1):48‑54.
Jacob G, Shannon JR, Black B, Biaggioni I, Mosqueda-Garcia R, Robertson RM, et al. Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation. 15 July 1997;96(2):575‑80.
Ruzieh M, Dasa O, Pacenta A, Karabin B, Grubb B. Droxidopa in the treatment of postural orthostatic tachycardia Syndrome. Am J Ther. Mar/Apr 2017;24(2):e157‑61.
Ishitobi M, Haginoya K, Kitamura T, Munakata M, Yokoyama H, Iinuma K. Acute dysautonomia: complete recovery after two courses of IVIg. Brain Dev. déc 2004;26(8):542‑4.
Gibbons CH, Vernino SA, Freeman R. Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy. Arch Neurol. Feb 2008;65(2):213‑7.